What compliance requirements must investigators and institutions agree to?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What compliance requirements must investigators and institutions agree to?

The main idea here is what investigators and their institutions commit to under Good Clinical Practice: conduct the trial exactly as the approved protocol, follow GCP standards, and keep essential study records for the required retention period. Sticking to the protocol ensures the study design, procedures, endpoints, and analyses are carried out as planned, which supports reliable and credible results and participant safety. Following GCP covers ethical and regulatory responsibilities—protecting participants’ rights and welfare, ensuring informed consent is properly obtained and documented, and maintaining accurate, verifiable data and accountability throughout the study. Keeping essential documents for the required retention period creates an auditable trail that regulators can review if needed. This includes the protocol and amendments, approvals from ethics committees or IRBs, informed consent forms, source documents, case report forms, and other trial records. Retention guarantees that if questions arise later about how the study was conducted or what happened to participants, there is a traceable record. Publishing results, while important for scientific dissemination, is not a mandatory compliance requirement of GCP. Submitting budgets to sponsors is a financial or administrative task, not a GCP obligation. Obtaining consent forms from regulatory authorities is not correct—consent is obtained directly from study participants, with appropriate documentation, not issued by regulatory authorities.

The main idea here is what investigators and their institutions commit to under Good Clinical Practice: conduct the trial exactly as the approved protocol, follow GCP standards, and keep essential study records for the required retention period. Sticking to the protocol ensures the study design, procedures, endpoints, and analyses are carried out as planned, which supports reliable and credible results and participant safety. Following GCP covers ethical and regulatory responsibilities—protecting participants’ rights and welfare, ensuring informed consent is properly obtained and documented, and maintaining accurate, verifiable data and accountability throughout the study.

Keeping essential documents for the required retention period creates an auditable trail that regulators can review if needed. This includes the protocol and amendments, approvals from ethics committees or IRBs, informed consent forms, source documents, case report forms, and other trial records. Retention guarantees that if questions arise later about how the study was conducted or what happened to participants, there is a traceable record.

Publishing results, while important for scientific dissemination, is not a mandatory compliance requirement of GCP. Submitting budgets to sponsors is a financial or administrative task, not a GCP obligation. Obtaining consent forms from regulatory authorities is not correct—consent is obtained directly from study participants, with appropriate documentation, not issued by regulatory authorities.

More practice questions